肝细胞癌经动脉栓塞治疗后腹膜转移:一项观察性研究
该观察性研究搜索影像报告与图像,识别出5例肝细胞癌经动脉栓塞(包括单纯栓塞、传统TACE及多柔比星洗脱微球TACE)后新发腹膜转移的患者,总结其共同特征:平均最大肿瘤直径3.7 cm(范围1.4-11.9 cm),3例有腹水且治疗肿瘤位于肝右叶后段,全部为包膜下肿瘤,平均4个月出现腹膜转移。作者认为腹膜转移是包膜下肝细胞癌经动脉栓塞后罕见但可能的并发症,尤其见于腹水及右叶后段肿瘤患者,影像科医生阅片时应评估腹膜转移。
要点
- 包膜下肝细胞癌经动脉栓塞后出现新发腹膜转移的平均时间为4个月
- 3例患者有腹水且治疗肿瘤位于肝右叶后段,全部患者均为包膜下肿瘤
- 解读肝细胞癌经动脉栓塞后影像时,应评估有无腹膜转移
核心结论
- 腹膜转移应被视为包膜下肝细胞癌经动脉栓塞后罕见但可能的并发症,尤其见于有腹水及右叶后段肿瘤的患者;作者认为规划肝细胞癌经动脉治疗时或许应考虑这一潜在并发症,影像科医生在解读经动脉栓塞后影像时应评估腹膜转移。
研究设计与样本
- 观察性研究,通过搜索电子放射学报告和图像识别5例经动脉栓塞(包括单纯栓塞、传统TACE及多柔比星洗脱微球TACE)治疗肝细胞癌前后均有影像、且治疗后新发腹膜转移的患者,记录患者人口学及肿瘤特征。
关键影像表现/征象
- 治疗肝细胞癌的平均最大直径为3.7 cm(范围1.4-11.9 cm)。
- 3例患者有腹水且治疗肿瘤位于肝右叶后段,全部患者均为包膜下肿瘤接受经动脉栓塞。
- 从经动脉栓塞治疗到出现腹膜转移的平均时间为四个月。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Transarterial embolization is frequently used to treat local hepatocellular carcinoma (HCC). While various complications are known to occur following transarterial embolization, only one prior case of peritoneal spread of HCC occurring shortly after transarterial chemoembolization has been reported. We present five cases of peritoneal spread of HCC following transarterial embolization (including bland embolization, conventional transarterial chemoembolization (TACE), and doxorubicin-eluting beads TACE) and identify features common among those cases.
METHODS: Search of electronic radiology reports and images identified five patients with imaging before and after treatment of HCC with transarterial embolization and with newly developed peritoneal metastases after treatment. Various patient demographics and tumor characteristics were noted.
RESULTS: The mean maximal diameter of the treated HCC tumors was 3.7 cm (range 1.4-11.9 cm). Three of the patients had ascites and treated tumors in the posterior right hepatic lobe, and all patients had subcapsular tumors treated with transarterial embolization before developing peritoneal metastases. The mean time from treatment with transarterial embolization to the development of peritoneal metastases was four months.
CONCLUSIONS: Intraperitoneal metastatic disease should be considered a rare but potential complication of transarterial embolization of subcapsular HCC, particularly in patients with ascites and tumors that are in the posterior segments of the right lobe. This potential complication should perhaps be considered when planning transarterial HCC treatment, and radiologists interpreting imaging after transarterial embolization of HCC should assess for peritoneal metastases.
引用
- Meier JM, Behr SC, Jordan E, et al. Intraperitoneal metastases after transarterial embolization of hepatocellular carcinoma: An observational study. Abdom Radiol (NY). 2017. PMID: 28197682. doi:10.1007/s00261-017-1071-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。